# Combination Chemotherapy in Treating Women With Breast Cancer

> **NCT00003679** · PHASE3 · UNKNOWN · sponsor: **Scottish Cancer Therapy Network** · enrollment: 350 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** docetaxel
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** tamoxifen citrate
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003679
- **Lead sponsor:** Scottish Cancer Therapy Network
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003679, "Combination Chemotherapy in Treating Women With Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*